When treatment side effects become a new problem, two seemingly unrelated therapeutic approaches join forces to solve a key dilemma in cancer treatment.

In oncology, photothermal therapy has garnered significant attention for its precise local hyperthermia. However, the inflammatory response it triggers often leads to tumor regeneration. Meanwhile, seemingly gentle hydrogen, with its anti-inflammatory and antioxidant properties, is emerging as an ideal partner to address this limitation.

Recent research indicates that combining hydrogen with photothermal therapy not only significantly enhances efficacy but also reduces treatment side effects. What are the mechanisms behind this synergy, and how is it achieved?

01 The Dilemma: Post-Photothermal Therapy Sequelae

Photothermal therapy utilizes photothermal conversion materials to generate localized high temperatures under near-infrared irradiation, directly killing tumor cells. This method is highly targeted and acts quickly, making it an important option in cancer treatment.

However, clinical observations have revealed a thorny issue following standalone photothermal therapy: the necrosis of tumor cells caused by high temperatures can trigger local or even systemic inflammatory responses. These inflammations not only cause pain and discomfort but, more critically, may stimulate the regeneration of residual tumor cells.

"The treatment creates a new problem. It's like using a fierce fire to burn weeds, but simultaneously fertilizing the soil, making the weeds more likely to regrow," researchers described. Controlling inflammation while eradicating the tumor became key to improving the efficacy of photothermal therapy.

02 Synergy: Hydrogen Counters Inflammation

It is against this backdrop that hydrogen therapy captured researchers' attention. As early as 1975, studies indicated that high-pressure hydrogen could inhibit tumor growth in mice with squamous cell carcinoma, and subsequent research confirmed hydrogen's significant anti-inflammatory effects.

Hydrogen can downregulate various pro-inflammatory factors, including key inflammatory mediators such as IL-1β, IL-6, and TNF-α. By modulating TLR4-mediated signaling pathways, hydrogen effectively controls inflammatory responses and reduces tissue damage.

More importantly, hydrogen also possesses selective antioxidant capacity, neutralizing the most toxic radicals like hydroxyl radicals while activating the body's endogenous antioxidant enzyme system, reducing inflammation caused by oxidative stress at its source.

When hydrogen meets photothermal therapy, a synergistic effect is born. Photothermal therapy kills tumor cells, while hydrogen inhibits the resulting inflammatory response, forming a complete "attack-repair" therapeutic闭环.

03 Enhancement: Dual Mechanisms Boost Efficacy

The synergy extends beyond side effect control to efficacy enhancement. Research has found that hydrogen can regulate the redox state of the tumor microenvironment, making cancer cells more susceptible to heat therapy.

Tumor microenvironments typically harbor abnormally high levels of reactive oxygen species, which fuel the rapid proliferation of cancer cells. Hydrogen can reduce these ROS levels, disrupting the redox balance that cancer cells depend on.

Furthermore, hydrogen has been found to activate caspase-independent apoptotic pathways, inducing programmed cell death in tumor cells. When combined with photothermal therapy, the direct damage from hyperthermia and the apoptosis induced by hydrogen create a dual attack mechanism.

"We observed that incorporating hydrogen therapy can reduce the required photothermal intensity by more than 30%, while achieving enhanced therapeutic outcomes," the research team reported. This means significantly less damage to normal tissues and improved patient tolerability.

04 The Carrier: The Dual Mission of Nanomaterials

The key to achieving synergistic hydrogen and photothermal therapy lies in the development of intelligent nanomaterials. These materials must not only facilitate efficient photothermal conversion but also carry and controllably release hydrogen.

PdH₀.₂ nanocrystals are representative of such materials. They possess both strong near-infrared absorption properties and high hydrogen loading capacity, capable of generating heat and releasing hydrogen upon laser irradiation, achieving "one material, two uses".

Metal-organic frameworks offer another design approach. By embedding palladium hydride within the framework structure, researchers have prepared multifunctional nanoplatforms featuring high hydrogen loading, good photothermal effects, and excellent imaging capabilities.

A more creative approach involves nanoreactors mimicking photosynthesis. These systems contain components like chlorophyll analogs and gold nanoparticles. Under light, they can "produce" hydrogen much like plants, while simultaneously completing photothermal conversion, truly realizing integrated "light-to-therapy" transformation.

05 Precision: Smart Response and Targeted Delivery

To further enhance the precision of synergistic therapy, researchers have designed environmentally responsive nanosystems. These systems release hydrogen specifically within the tumor microenvironment, achieving dual spatial and temporal control.

Characteristics of the tumor microenvironment, such as low pH and high enzyme activity, are ingeniously utilized. For example, using mesoporous silica-coated ammonia borane nanoparticles ensures that hydrogen is generated only upon decomposition in the acidic tumor environment, avoiding side effects on normal tissues.

Externally stimulated responsive systems are also rapidly developing. Besides commonly used near-infrared light, ultrasound and magnetic fields are being employed to trigger hydrogen release. Notably, ultrasound-responsive systems can provide real-time imaging, allowing physicians to "see" the distribution of hydrogen within the tumor.

Importantly, nanomaterials themselves can accumulate in tumor sites via the enhanced permeability and retention effect. This passive targeting, potentially combined with active targeting modifications, ensures that substantial amounts of hydrogen are precisely delivered to the tumor region.

06 Future: From Synergy to Integration

The synergy between hydrogen and photothermal therapy represents a shift in therapeutic philosophy — from single modalities to combination strategies, from單純 killing to microenvironment modulation.

Looking ahead, this synergistic strategy could be further expanded. Combinations of hydrogen with radiotherapy, chemotherapy, and immunotherapy also show promise. Particularly, combining it with immunotherapy might activate systemic anti-tumor immunity to combat distant metastases.

With the advancement of precision medicine and nanotechnology, hydrogen therapy is evolving from simple gas inhalation to intelligently controlled, targeted treatment. Through精心 designed nanoplatforms, hydrogen can be released at the right time, in the right place, and at the right dose.

When two therapeutic approaches are no longer simply叠加 but are deeply integrated and mutually enhancing, the effectiveness of cancer treatment may undergo a qualitative leap. The synergy between hydrogen and photothermal therapy might just be the beginning of this transformation.

The views presented here are based on an interpretation of the article Hydrogen Gas from Inflammation Treatment (ACS Nano 2019, 13 (8), 8505-8511, ) and are intended for sharing purposes only. They do not constitute any form of treatment advice.